Initial results from the TRILUMINATE trial show Abbott Laboratories Inc.’s transcatheter tricuspid valve repair (TTVR) system can significantly reduce tricuspid regurgitation and improve heart failure symptoms.
Tricuspid regurgitation, a backward flow of blood from the heart’s right ventricle through the tricuspid valve into the right atrium, can eventually cause right-heart failure
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?